National Center for Advancing Translational Sciences; Notice of Meeting, 26060 [2021-10021]
Download as PDF
<![CDATA[
26060
Federal Register / Vol. 86, No. 90 / Wednesday, May 12, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Pilot
Effectiveness Trials for Treatment,
Prevention, and Services Interventions (R34).
Date: June 8, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6000, MSC 9606,
Bethesda, MD 20852, 301–500–5829,
serena.chu@nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Device Development.
Date: June 9, 2021.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Nicholas Gaiano, Ph.D.,
Review Branch Chief, Division of Extramural
Activities, National Institute of Mental
Health, NIH, Neuroscience Center/Room
6150/MSC 9606, 6001 Executive Boulevard,
Bethesda, MD 20892–9606, 301–443–2742,
nick.gaiano@nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Mood
Disorders in People Living with HIV:
Mechanisms and Pathways (R01 & R21).
Date: June 9, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
VerDate Sep<11>2014
17:58 May 11, 2021
Jkt 253001
Dated: May 7, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10026 Filed 5–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://videocast.
nih.gov). Individuals who plan to attend
and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: June 10–11, 2021.
Closed: June 10, 2021, 11:00 a.m. to 12:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Room 987/987,
Bethesda, MD 20892 (Virtual Meeting).
Open: June 10, 2021, 1:00 p.m. to 4:00 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Room 987/987,
Bethesda, MD 20892 (Virtual Meeting).
Open: June 11, 2021, 1:00 p.m. to 5:00 p.m.
Agenda: To view and discuss Clearance of
Concepts.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Room 987/987,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences,
National Institutes of Health, One Democracy
Plaza, 6701 Democracy Boulevard, Room
1072, Bethesda, MD 20892, 301–435–0809,
anna.ramseyewing@nih.gov.
Attendees and interested parties may
submit questions and comments through
written Q&A during the meeting, and for 15
days after the meeting, to
NCATSCouncilInput@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: May 7, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10021 Filed 5–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee (CTAC) Ad
hoc Translational Research Strategy
Subcommittee.
Date: June 17, 2021.
Time: 11:00 a.m. to 12:00 p.m.
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 86, Number 90 (Wednesday, May 12, 2021)]
[Notices]
[Page 26060]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10021]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Center for
Advancing Translational Sciences Advisory Council.
The meeting will be open to the public as indicated below. The open
session will be videocast and can be accessed from the NIH Videocasting
and Podcasting website (https://videocast.nih.gov). Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Advisory Council.
Date: June 10-11, 2021.
Closed: June 10, 2021, 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 987/987, Bethesda, MD 20892 (Virtual Meeting).
Open: June 10, 2021, 1:00 p.m. to 4:00 p.m.
Agenda: Report from the Institute Director and other staff.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 987/987, Bethesda, MD 20892 (Virtual Meeting).
Open: June 11, 2021, 1:00 p.m. to 5:00 p.m.
Agenda: To view and discuss Clearance of Concepts.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 987/987, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive
Secretary, National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 1072, Bethesda, MD 20892, 301-435-0809,
[email protected].
Attendees and interested parties may submit questions and
comments through written Q&A during the meeting, and for 15 days
after the meeting, to [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice no later than 15 days after the meeting. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: May 7, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-10021 Filed 5-11-21; 8:45 am]
BILLING CODE 4140-01-P
